Synthetic vascular prosthesis likewise vascular endoprosthesis are prone to several complications after implantation into the human body. Infections, thromboses and late occlusions are the most challenging and the most common, leading to serious clinical consequences that are sometimes lethal. Management of those complications is still fraught with tremendous difficulties justifying the economic burden and the continuous efforts in research development for improving vascular prosthetic materials. This research investment is, however, yet to yield any great clinical advance. Previous studies conducted in our research laboratory have led to the development of polyester vascular prostheses coated with a polymer of hydroxypropyl-β-cyclodextrin. This was achieved in order to increase the loading and eluting capacities of these vascular prostheses towards several antibiotics. In the current works, we sought to determine the optimal conditions for effective controlled release of three antibiotics from those prosthetic platforms. We have also evaluated their efficacy in both in vitro and in vivo models of vascular infections. This was carried-out against nine different bacteria strains that are among the most common in human vascular infections. Moreover, we have assessed in vivo their safety, their healing properties, their systemic toxicity and their biocompatibility in the prospect of clinical application.The above-mentioned drug delivery system has been proved to be effective in releasing in situ the selected antibacterial agents over a seven-day desorption period in human plasma. Optimal batch concentration and time for prosthetic immersion into the antibiotic solutions were well compatible with current surgical practice standards. A bactericidal activity evidenced by significant reduction of bacterial adhesion, growth and proliferation was revealed when compared to appropriate controls in the various tested vascular infection models. We have also studied antibacterial molecules alone or in combination. In this latter setting, no antagonistic effects were depicted. This provides a unique opportunity to customize local antibiotic treatment delivered in situ from vascular device fabrics and to adapt it to the evolving ecology of both monomicrobial and polymicrobial vascular prosthetic infection. The polyester vascular prostheses coated with a polymer of hydroxypropyl-β-cyclodextrin were proved in vivo safe and demonstrated excellent biocompatibility, healing properties and tissue integration without any signs of systemic toxicity. [...]